Moreover, the nature of the interactions with Bcl-XL and the observation that in healthy cells Bim is not bound to anti-apoptotic proteins suggest it may be possible to generate a pair of small molecules that selectively kill cancer cells by efficiently releasing Bim from or preventing Bim binding to Bcl-2 and Bcl-XL. Here, BCL2L11 is linked to cancer.